At the news
? NEUTRALIMPACT 2/10 144 filed Aug 4, 2026 at 18:09 ET
Director Christine Cournoyer filed a Form 144 notice to sell 16,000 common shares of CareDx with an estimated market value of $753,440. The shares were acquired as RSU compensation in 2025. The proposed sale is small relative to CareDx's $2.5B market cap (0.03%) and represents routine insider diversification.
- Director Christine Cournoyer intends to sell 16,000 shares via Goldman Sachs.
- Estimated market value of proposed sale is $753,440.
- Shares were acquired as RSU compensation on 06/14/2025 (10,570 shares) and 03/07/2025 (5,430 shares).
- The sale represents less than 0.03% of CareDx's market capitalization.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access